Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Protillion Biosciences specializes in the design and development of protein-based drugs.
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Mindstrong is a virtual mental health platform.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Happy Health is a mission-driven technology company
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Feelmore Labs is an innovative health & wellness technology company.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
AgBiome discovers and develops innovative biological and trait products for crop protection.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Atlas Data Storage is an information technology company focused on data storage solutions.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
ARCH Venture Partners has invested in 239 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Biopharma. The firm invests across 32 different industry categories.
Among tracked funding rounds, Altos Labs received $3.0B in a Series A round. ARCH Venture Partners's total known invested capital is $31.3B.
ARCH Venture Partners's average investment size is $131.1M across its portfolio of 239 companies.
Recent ARCH Venture Partners portfolio additions include Aera Therapeutics, Protillion Biosciences, Carrick Therapeutics, Faraday Pharmaceuticals, hC Bioscience. These companies were founded in 2020 or later.